225 related articles for article (PubMed ID: 27633176)
1. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
[TBL] [Abstract][Full Text] [Related]
2. Expression of CTGF and Cyr61 in colorectal cancer.
Ladwa R; Pringle H; Kumar R; West K
J Clin Pathol; 2011 Jan; 64(1):58-64. PubMed ID: 21081514
[TBL] [Abstract][Full Text] [Related]
3. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
[TBL] [Abstract][Full Text] [Related]
5. Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.
Zhang H; Li W; Huang P; Lin L; Ye H; Lin D; Koeffler HP; Wang J; Yin D
Oncol Rep; 2015 Mar; 33(3):1481-92. PubMed ID: 25571929
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
[TBL] [Abstract][Full Text] [Related]
7. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.
Xie D; Yin D; Wang HJ; Liu GT; Elashoff R; Black K; Koeffler HP
Clin Cancer Res; 2004 Mar; 10(6):2072-81. PubMed ID: 15041728
[TBL] [Abstract][Full Text] [Related]
8. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
Zeng ZJ; Yang LY; Ding X; Wang W
World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
[TBL] [Abstract][Full Text] [Related]
9. Cyr61/CTGF/Nov family proteins in gastric carcinogenesis.
Cheng TY; Wu MS; Hua KT; Kuo ML; Lin MT
World J Gastroenterol; 2014 Feb; 20(7):1694-700. PubMed ID: 24587648
[TBL] [Abstract][Full Text] [Related]
10. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
Brigstock DR
Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
[TBL] [Abstract][Full Text] [Related]
11. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
Watari H; Xiong Y; Hassan MK; Sakuragi N
Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
[TBL] [Abstract][Full Text] [Related]
13. Three members of the connective tissue growth factor family CCN are differentially regulated by mechanical stress.
Schild C; Trueb B
Biochim Biophys Acta; 2004 Apr; 1691(1):33-40. PubMed ID: 15053922
[TBL] [Abstract][Full Text] [Related]
14. Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
Bartel F; Balschun K; Gradhand E; Strauss HG; Dittmer J; Hauptmann S
Int J Gynecol Pathol; 2012 Sep; 31(5):405-15. PubMed ID: 22833079
[TBL] [Abstract][Full Text] [Related]
15. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Maeta N; Osaki M; Shomori K; Inaba A; Kidani K; Ikeguchi M; Ito H
Oncology; 2007; 73(1-2):118-26. PubMed ID: 18337624
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.
Yin J; Cui Y; Li L; Ji J; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4489-4497. PubMed ID: 28739744
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
18. Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells.
Li J; Ye L; Sun PH; Zheng F; Ruge F; Satherley LK; Feng Y; Zhao H; Du G; Wang T; Yang Y; Ma X; Cheng S; Yang X; Yu H; Teng X; Si Y; Zhang Z; Jiang WG
Oncotarget; 2017 Apr; 8(16):26231-26244. PubMed ID: 28412738
[TBL] [Abstract][Full Text] [Related]
19. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
20. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
